15.02.2022 CompuGroup Medical SE & Co. KGaA  DE000A288904

DGAP-News: CompuGroup Medical strengthens Management Board for sustainable growth


 

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel
CompuGroup Medical strengthens Management Board for sustainable growth

15.02.2022 / 08:17
The issuer is solely responsible for the content of this announcement.


  • Angela Mazza Teufer strengthens Management Board with focus on accelerating digitization and connectivity within the Ambulatory Information Systems DACH
  • Emanuele Mugnani promoted to the Board as Managing Director for Ambulatory Information Systems Europe, continuing the growth story
  • Focus on digitization in doctors' practices and the healthcare sector


Koblenz. CompuGroup Medical (CGM), one of the leading e-health providers worldwide, is strengthening its Management Board. Angela Mazza Teufer joins the board of CompuGroup Medical Management SE as Managing Director Ambulatory Information Systems DACH as of February 15, 2022, together with Emanuele Mugnani, a long-term member of the CGM leadership team, who is going to serve as Managing Director Ambulatory Information Systems Europe. Dr. Eckart Pech, Managing Director Consumer and Health Management Information Systems will continue to serve for another five years responsible for the growing business with industry, consumers and data-based solutions in the CHS segment. Frank Gotthardt, Chairman of the Administrative Board, says:" I am very pleased that we have a first-class management team with deep industry experience, proven digital transformation experience and tremendous levels of energy to drive our long-term growth focusing on excellent customer service and innovation."

Focus on the significance of digitization in doctor's practices

The new board members focus on the increasing digitization in doctor's practices and pharmacies including connectivity services for patients. Angela Mazza Teufer will play a central role in both fields. She will also assume responsibility for the Telematics Infrastructure (TI) in Germany. Born in Italy, she is a proven expert in the digital transformation and the optimization of value creation on the customer side through ERP (Enterprise Resource Planning) systems. She began her career in 2002 in various management positions in different IT companies. She is joining from Oracle as Senior Vice President for ERP, EPM (Enterprise Performance Management) and SCM (Supply Chain Management) Europe, before this she worked for more than 13 years in various management positions at SAP, most recently as Region President.

"Angela is a fantastic leader, highly respected in the industry, with great expertise in cloud solutions, artificial intelligence and digital process control solutions with a zeal for excellence. Emanuele is a proven e-health expert driving efficiency and quality, he knows the CGM business and our customers in detail and has a great track record," CGM CEO Dr. Dirk Wössner welcomes the Managing Directors. "These two are a perfect fit to further drive the digitization with a great passion for our customers."

Important AIS business under regional responsibility in the future

CGM's Ambulatory Information Systems (AIS) business mainly covers the DACH, Europe and USA regions. The business is subject to major transformation due to the increasing digitization in the healthcare sector. This results in numerous growth opportunities for CompuGroup Medical. In addition to Angela Mazza Teufer for the DACH countries, Emanuele Mugnani, is joining the board for AIS Europe. He will be also responsible for Pharmacy Information Systems (PCS). Emanuele Mugnani has been extremely successful with CGM for 8 years in various international roles among them running CGM's Pharmacy (PCS) business and being country manager for Italy. The US business will continue to be managed by Derek Pickell, who reports directly to CEO Dr. Dirk Wössner.

External segment reporting and further board setup remain unchanged

CGM's external segment reporting, split into the Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), Consumer & Health Management Information Systems (CHS), and Pharmacy Information Systems (PCS) segments, remains unchanged.

About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 837 million in 2020, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists, and other healthcare professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 8,500 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for media representatives:
Alexander Weimer / Michael Franz
Head of Brand Communication
P +49 (0) 261 8000-6100
E-mail: [email protected]

Contact for analysts and investors:
Claudia Thomé
Corporate Vice President Investor Relations
P: +49 160 3630362
E-mail: [email protected]



15.02.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1280475

 
End of News DGAP News Service

1280475  15.02.2022 

fncls.ssp?fn=show_t_gif&application_id=1280475&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 582,38 717,02 745,81 837,26 1.025,32 1.129,74 1.187,66
EBITDA1,2 128,44 187,84 178,13 197,48 213,39 216,35 229,76
EBITDA-Marge3 22,05 26,20 23,88 23,59 20,81 19,15
EBIT1,4 90,07 143,23 115,27 121,77 102,68 104,03 113,96
EBIT-Marge5 15,47 19,98 15,46 14,54 10,01 9,21 9,60
Jahresüberschuss1 31,74 96,34 66,15 73,42 69,03 74,12 46,87
Netto-Marge6 5,45 13,44 8,87 8,77 6,73 6,56 3,95
Cashflow1,7 85,82 136,35 110,50 149,93 165,27 145,03 179,53
Ergebnis je Aktie8 0,63 1,92 1,33 1,40 1,30 1,40 0,88
Dividende8 0,35 0,50 0,50 0,50 0,50 0,50 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
CompuGroup Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A28890 27,860 Halten 1.497,05
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
21,43 35,69 0,62 23,91
KBV KCV KUV EV/EBITDA
2,43 8,34 1,26 9,47
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,50 1,00 3,59 22.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-8,26% -23,40% -26,49% -44,01%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CompuGroup Medical SE & Co. KGaA  ISIN: DE000A288904 können Sie bei EQS abrufen


Software , A28890 , COP , XETR:COP